Secretase Targets for Alzheimer's Disease: Identification and Therapeutic Potential
- 1 June 2001
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (13), 2039-2060
- https://doi.org/10.1021/jm0004897
Abstract
No abstract availableThis publication has 160 references indexed in Scilit:
- Difluoro Ketone Peptidomimetics Suggest a Large S1 Pocket for Alzheimer's γ-Secretase: Implications for Inhibitor DesignJournal of Medicinal Chemistry, 2000
- L-685,458, an Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid β-Protein Precursor γ-Secretase ActivityBiochemistry, 2000
- Notch Signaling: Cell Fate Control and Signal Integration in DevelopmentScience, 1999
- An Essential Role for Ectodomain Shedding in Mammalian DevelopmentScience, 1998
- Mutations in the Transmembrane Domain of APP Altering γ-Secretase SpecificityBiochemistry, 1997
- Numb Antagonizes Notch Signaling to Specify Sibling Neuron Cell FatesNeuron, 1996
- Sterol-Regulated Release of SREBP-2 from Cell Membranes Requires Two Sequential Cleavages, One Within a Transmembrane SegmentCell, 1996
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991